| __timestamp | Intra-Cellular Therapies, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 68205000 |
| Thursday, January 1, 2015 | 87718074 | 54218000 |
| Friday, January 1, 2016 | 93831530 | 15934000 |
| Sunday, January 1, 2017 | 79419009 | 24390000 |
| Monday, January 1, 2018 | 132166913 | 25389000 |
| Tuesday, January 1, 2019 | 89124838 | 72324000 |
| Wednesday, January 1, 2020 | 65782137 | 184809000 |
| Friday, January 1, 2021 | 88845513 | 205164000 |
| Saturday, January 1, 2022 | 134715000 | 245441000 |
| Sunday, January 1, 2023 | 180142000 | 271823000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc. have demonstrated varying levels of investment in R&D, reflecting their strategic priorities.
From 2014 to 2023, Madrigal Pharmaceuticals has consistently increased its R&D spending, culminating in a 300% rise by 2023. This surge underscores Madrigal's aggressive pursuit of groundbreaking therapies. In contrast, Intra-Cellular Therapies, while also increasing its R&D budget, has shown a more moderate growth of approximately 750% over the same period.
The data reveals a fascinating trend: while both companies are committed to innovation, Madrigal's recent years show a more pronounced acceleration in R&D investment, potentially positioning it as a leader in the biotech innovation race.
Research and Development Expenses Breakdown: Amgen Inc. vs Madrigal Pharmaceuticals, Inc.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Insights: How Genmab A/S and Madrigal Pharmaceuticals, Inc. Allocate Funds
Incyte Corporation or Madrigal Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Apellis Pharmaceuticals, Inc.
R&D Spending Showdown: Madrigal Pharmaceuticals, Inc. vs Galapagos NV